Summary
3M Company reported a slight decrease in net sales for the first quarter of 2022 compared to the same period in 2021, with total net sales of $8,829 million versus $8,851 million. Operating income saw a more significant decline, dropping to $1,641 million from $1,994 million in the prior year, reflecting increased operating expenses and the impact of significant litigation costs. Diluted earnings per share decreased to $2.26 from $2.77 year-over-year. The company highlighted challenges from increased raw material and logistics costs, as well as ongoing supply chain headwinds. Despite these pressures, 3M emphasized its strong organic sales growth in certain segments, particularly Health Care, and continued commitment to returning capital to shareholders through dividends and share repurchases, marking its 64th consecutive year of dividend increases. Management is actively managing its portfolio and investing in growth, productivity, and sustainability initiatives.
Financial Highlights
54 data points| Revenue | $8.83B |
| Cost of Revenue | $4.83B |
| Gross Profit | $4.00B |
| SG&A Expenses | $1.88B |
| Operating Expenses | $7.19B |
| Operating Income | $1.64B |
| Interest Expense | $113.00M |
| Net Income | $1.30B |
| EPS (Basic) | $2.27 |
| EPS (Diluted) | $2.26 |
| Shares Outstanding (Basic) | 572.30M |
| Shares Outstanding (Diluted) | 575.00M |
Key Highlights
- 1Net sales were $8,829 million, a slight decrease of 0.3% compared to $8,851 million in Q1 2021.
- 2Operating income decreased by 17.7% to $1,641 million from $1,994 million in Q1 2021.
- 3Diluted earnings per share declined to $2.26 from $2.77 year-over-year.
- 4The company experienced significant increases in raw material and logistics costs, contributing to margin pressures.
- 5Significant litigation costs, particularly related to respirator mask/asbestos and Combat Arms Earplugs matters, impacted operating results, with a notable increase in adjusted operating income margin in the Safety and Industrial segment when excluding these costs.
- 6Organic sales showed resilience in certain segments, with Health Care up 4.7% and Consumer up 3.4%.
- 73M continued to return capital to shareholders, with $773 million in stock repurchases and a 1% increase in its quarterly dividend, marking its 64th consecutive year of dividend increases.